|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities: | |||||
| Amortization of premiums and accretion of discounts on securities, net | |||||
| Depreciation and amortization expense | |||||
| Deferred income taxes | |||||
| Stock compensation expense | |||||
| Increase in cash value of life insurance | |||||
| Gain on life insurance | |||||
| Loss (gain) on sale of securities | |||||
| Provision for credit losses | |||||
| Proceeds from sales of loans | |||||
| Loans originated for sale | |||||
| Gain on sale of loans | |||||
| Amortization of tax credit investment | |||||
| Unrealized (gain) loss on equity securities | |||||
| Net realized and unrealized gain on foreclosed real estate | |||||
| Loss (gain) on disposal of premises and equipment | |||||
| (Increase) decrease in accrued interest receivable | |||||
| Increase in accrued interest payable | |||||
| Net change in other assets/liabilities | |||||
| Net Cash Provided By Operating Activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Net decrease (increase) in interest-bearing time deposits | |||||
| Purchase of securities available for sale | |||||
| Purchase of securities held to maturity | |||||
| Proceeds from maturities of securities available for sale | |||||
| Proceeds from sales of securities available for sale | |||||
| Principal collected on mortgage-backed obligations | |||||
| Proceeds from sale of equity securities | |||||
| Net increase in loans receivable | |||||
| Investment in tax credit entities | |||||
| Investment in technology fund | |||||
| Proceeds from settlement of bank-owned life insurance policies | |||||
| Proceeds from sale of foreclosed real estate | |||||
| Proceeds from redemption of Federal Home Loan Bank stock | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from insurance claims | |||||
| Purchase of premises and equipment | |||||
| Net Cash (Used In) Provided By Investing Activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Net increase (decrease) in deposits | |||||
| Advances from FHLB and BTFP | |||||
| Repayment of advances from the FHLB and BTFP | |||||
| Purchase of treasury stock | |||||
| Taxes paid on stock award shares for employees | |||||
| Dividends paid | |||||
| Net Cash Provided By (Used In) Financing Activities | |||||
| Net Increase (Decrease) in Cash and Cash Equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and Cash Equivalents at End of Period | |||||
Loading...